Company Filing History:
2 out of 6 
1 out of 7 
1 out of 142 
Years Active: 1988-1995
Title: Pradip Ghosh-Dastidar: Innovator in Genetic Engineering
Introduction
Pradip Ghosh-Dastidar, based in Los Angeles, CA, is a distinguished inventor with a notable contribution to genetic engineering, holding a total of four patents. His groundbreaking work primarily focuses on the synthesis of proteins and the identification of regression-associated antigens in cancer diagnostics.
Latest Patents
Among his latest patents, Ghosh-Dastidar has worked on DNA encoding, specifically the patents ASP 113 and LYS 46, ASP 113 related to thaumatin I. The genes disclosed in these patents enable the synthesis of two analogues of thaumatin I in selected host microorganisms. His work emphasizes the importance of aspartate and lysine amino acid residues at specific positions within the protein's structure. Another innovative patent involves the cloning of a 38kd Mycoplasma hyorhinis regression-associated antigen. This research identifies regression-associated antigens by their immunological reaction with regression antibodies in cancer patients. The patents highlight the potential for these antigens and related antibodies in diagnostic assays and immunotherapy, showcasing a significant advancement in cancer treatment and monitoring.
Career Highlights
Ghosh-Dastidar has made significant strides in his career, with his innovative research being conducted at reputable companies such as Beatrice Companies, Inc. and International Genetic Engineering. His work has not only provided valuable insights into genetic engineering but also holds promise for the future of cancer therapy and diagnosis.
Collaborations
Throughout his career, Ghosh-Dastidar has collaborated with notable individuals in the field, including George C. Fareed and Arup Sen. These collaborations have enriched his research and contributed to the advancement of genetic studies, showcasing the importance of teamwork in scientific innovation.
Conclusion
Pradip Ghosh-Dastidar stands out as a significant figure in the realm of genetic engineering, with his innovative patents reflecting a commitment to improving cancer diagnostics and treatments. His contributions continue to shape the future of medical science, making it an exciting area of research for ongoing advancements.